Iterum Therapeutics plc — Form D
Iterum Therapeutics plc of DUBLIN, L2, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-12. The offering totals $2.8M, of which $2.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-06-12
- Form: D
- Accession: 0001659323-20-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.8M
- Amount sold: $2.8M
- Investors: 8
- Date of first sale: 2020-06-05
- Revenue range: Decline to Disclose
- SEC file number: 021-368874
Issuer
- Name: Iterum Therapeutics plc
- CIK: 0001659323
- Entity type: Corporation
- Jurisdiction: IRELAND
- Incorporated: 2015
- Address: BLOCK 2 FLOOR 3, HARCOURT CENTRE, DUBLIN, L2, 2
- Phone: (872) 225-6077
Officers, directors & promoters (24)
| Name | Role | Location |
|---|
| Ronald M Hunt | Director | New York, NY |
| James I Healy | Director | DORADO, PR |
| Shahzad M Malik | Director | Dublin, L2 |
| Judith M Matthews | Executive Officer | Dublin, L2 |
| Judith M Matthews | Promoter | Dublin, L2 |
| Michael M Dunne | Executive Officer | Dublin, L2 |
| Mark K Chin | Director | Dublin, L2 |
| Louise M Barrett | Executive Officer | Dublin, L2 |
| Brenton K Ahrens | Director | Dublin, L2 |
| Corey N Fishman | Director | Dublin, L2 |
| Corey N Fishman | Executive Officer | Dublin, L2 |
| Corey N Fishman | Promoter | Dublin, L2 |
| Patrick J Heron | Director | Menlo Park, CA |
| Mark I Chin | Director | Dublin, L2 |
| Michael W Dunne | Executive Officer | Dublin, L2 |
| Michael W Dunne | Promoter | Dublin, L2 |
| Robert I Hopfner | Director | Dublin, L2 |
| Shahzad I Malik | Director | Dublin, L2 |
| Jeff I Schaffnit | Executive Officer | Dublin, L2 |
| David I Kelly | Director | Dublin, L2 |
| Paul R Edick | Director | Dublin, L2 |
| Tracy I Saxton | Director | Dublin, L2 |
| Patrick N Heron | Director | Dublin, L2 |
| David M Kelly | Director | Westfield, MA |
Other filings by this issuer (5)
More